Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Silver RT. Update on the treatment of polycythemia vera with recombinant interferon alfa or imatinib mesylate. Curr Hematol Malig Rep 2007;2:43-6. [DOI: 10.1007/s11899-007-0006-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]

For:	Silver RT. Update on the treatment of polycythemia vera with recombinant interferon alfa or imatinib mesylate. Curr Hematol Malig Rep 2007;2:43-6. [DOI: 10.1007/s11899-007-0006-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]

Number	Cited by Other Article(s)
1	Treatment of polycythemia vera with imatinib mesylate. Leuk Res 2012;36:156-62. [DOI: 10.1016/j.leukres.2011.09.001] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2011] [Revised: 08/31/2011] [Accepted: 09/02/2011] [Indexed: 11/18/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Treatment of polycythemia vera with imatinib mesylate. Leuk Res 2012;36:156-62. [DOI: 10.1016/j.leukres.2011.09.001] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2011] [Revised: 08/31/2011] [Accepted: 09/02/2011] [Indexed: 11/18/2022]